MiR-182 is associated with growth, migration and invasion in prostate cancer via suppression of FOXO1

Journal of Cancer

Volumn 6, Issue 12, 2015, Pages 1295-1305

  Wallis, Christopher J D ^a   Gordanpour, Aida ^b   Bendavid, Jessica Stojcic ^a   Sugar, Linda ^a   Nam, Robert K ^a   Seth, Arun ^a,b,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Canada   (Canada)

Author keywords

MicroRNA; Prostatectomy; Prostatic neoplasms

Indexed keywords

MICRORNA 182; TRANSCRIPTION FACTOR FKHR;

ADULT; AGED; ALGORITHM; ARTICLE; BIOCHEMICAL RECURRENCE; CANCER GROWTH; CANCER RECURRENCE; CELL MIGRATION; CELL PROLIFERATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LNCAP CELL LINE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROSTATECTOMY; TUMOR INVASION; WESTERN BLOTTING;

EID: 84954491116     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.13176     Document Type: Article

References (22)

1. Siadat F, Sykes J, Zlotta AR, et al. Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series. The Prostate. 2015.
2. Jung JW, Lee JK, Hong SK, Byun SS, Lee SE. Stratification of patients with intermediate-risk prostate cancer. BJU international. 2015;115(6):907-912.
3. Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer research. 2009;69(19):7495-7498.
4. Olsen PH, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol. 1999;216(2):671-680.
5. Eulalio A, Rehwinkel J, Stricker M, et al. Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing. Genes Dev. 2007;21(20):2558-2570.
6. Bagga S, Bracht J, Hunter S, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 2005;122(4):553-563.
7. Xu S, Witmer PD, Lumayag S, Kovacs B, Valle D. MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. The Journal of biological chemistry. 2007;282(34):25053-25066.
8. Segura MF, Hanniford D, Menendez S, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(6):1814-1819.
9. Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. The Journal of biological chemistry. 2009;284(35):23204-23216.
10. Casanova-Salas I, Rubio-Briones J, Calatrava A, et al. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. The Journal of urology. 2014;192(1):252-259.
11. Gordanpour A, Stanimirovic A, Nam RK, et al. miR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer. Anticancer Res. 2011;31(2):403-410.
12. Ambs S, Prueitt RL, Yi M, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer research. 2008;68(15):6162-6170.
13. Stittrich AB, Haftmann C, Sgouroudis E, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol. 2010;11(11):1057-1062.
14. Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1-6.
15. Lapointe J, Li C, Higgins JP, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(3):811-816.
16. LaTulippe E, Satagopan J, Smith A, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer research. 2002;62(15):4499-4506.
17. Tomlins SA, Mehra R, Rhodes DR, et al. Integrative molecular concept modeling of prostate cancer progression. Nature genetics. 2007;39(1):41-51.
18. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci. 2007;120(Pt 15):2479-2487.
19. Kau TR, Schroeder F, Ramaswamy S, et al. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer cell. 2003;4(6):463-476.
20. Dong XY, Chen C, Sun X, et al. FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer research. 2006;66(14):6998-7006.
21. Zhang H, Pan Y, Zheng L, et al. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer research. 2011;71(9):3257-3267.
22. Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature medicine. 2011;17(2):211-215.